Aktuelles
SiSaf and the University of Leipzig Partner to Develop Bio-Courier Targeted miRNA for the Treatment of Pancreatic Cancer - SiSaf Ltd
Pancreatic Cancer Therapy Using miRNA
Loop | Achim Aigner
Aktuelles
Achim Prof. Dr. Aigner – Professor – University of Leipzig, Rudolf-Boehm-Institute for Pharmacology and Toxicology | LinkedIn
Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology, Pharmacy and Toxicology | Research profile
Analysis of SATB1 in Head and Neck Squamous Cell Carcinoma
Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology, Pharmacy and Toxicology | Research profile
Partnership will develop targeted miRNAs to treat pancreatic cancer - Drug Discovery World (DDW)
Mitarbeiter des Rudolf-Boehm-Institutes
Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology, Pharmacy and Toxicology | Research profile
Mitarbeiter des Rudolf-Boehm-Institutes
Nanoparticle-mediated delivery of small RNA molecules in tumor therapy
PDF) Targeted CRM197-PEG-PEI/siRNA complexes for therapeutic RNAi in glioblastoma
Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology, Pharmacy and Toxicology | Research profile
Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology, Pharmacy and Toxicology | Research profile
Mitarbeiter des Rudolf-Boehm-Institutes
Pharmaceutics | Free Full-Text | Amphiphilic Anionic Oligomer-Stabilized Calcium Phosphate Nanoparticles with Prospects in siRNA Delivery via Convection-Enhanced Delivery
Wissenschaftlicher Mitarbeiter (m/w/d) Klinische Pharmakologie - Universität Leipzig, Medizinische Fakultät - academics
Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology, Pharmacy and Toxicology | Research profile
Björn Simon
Leipziger Pharmakologen forschen an Molekülen gegen Prostatakrebs
Neuartige Gentherapie zur Behandlung des Glioblastoms
